Apyx Medical Corp. (APYX)
2.645
-0.04
(-1.67%)
USD |
NASDAQ |
Oct 30, 11:08
Apyx Medical Gross Profit Margin (Quarterly) : 39.59% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 39.59% |
| March 31, 2026 | 37.41% |
| December 31, 2025 | 38.26% |
| September 30, 2025 | 39.65% |
| June 30, 2025 | 35.27% |
| March 31, 2025 | 27.40% |
| December 31, 2024 | 31.62% |
| September 30, 2024 | 30.00% |
| June 30, 2024 | 23.14% |
| March 31, 2024 | 12.23% |
| December 31, 2023 | 27.70% |
| September 30, 2023 | 27.65% |
| June 30, 2023 | 31.28% |
| March 31, 2023 | 20.63% |
| December 31, 2022 | 28.26% |
| September 30, 2022 | 20.69% |
| June 30, 2022 | 19.65% |
| March 31, 2022 | 24.32% |
| December 31, 2021 | 44.12% |
| September 30, 2021 | 32.54% |
| June 30, 2021 | 28.43% |
| March 31, 2021 | 18.70% |
| December 31, 2020 | 29.04% |
| September 30, 2020 | 17.50% |
| June 30, 2020 | -31.31% |
| Date | Value |
|---|---|
| March 31, 2020 | -6.54% |
| December 31, 2019 | 19.90% |
| September 30, 2019 | 28.18% |
| June 30, 2019 | 17.51% |
| March 31, 2019 | 1.33% |
| December 31, 2018 | -2.97% |
| September 30, 2018 | 8.82% |
| June 30, 2018 | 19.62% |
| March 31, 2018 | 12.07% |
| December 31, 2017 | 48.47% |
| September 30, 2017 | 2.26% |
| June 30, 2017 | 28.29% |
| March 31, 2017 | 20.73% |
| December 31, 2016 | 24.06% |
| September 30, 2016 | 28.52% |
| June 30, 2016 | 26.90% |
| March 31, 2016 | 15.73% |
| December 31, 2015 | 42.37% |
| September 30, 2015 | 16.62% |
| June 30, 2015 | 17.49% |
| March 31, 2015 | 11.78% |
| December 31, 2014 | 9.35% |
| September 30, 2014 | 3.92% |
| June 30, 2014 | 6.59% |
| March 31, 2014 | 27.77% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 57.05% |
| AngioDynamics, Inc. | 56.00% |
| Alphatec Holdings, Inc. | 62.90% |
| AtriCure, Inc. | 76.75% |
| Baxter International, Inc. | 39.11% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -80.03% |
| Return on Assets | -13.72% |
| Return on Invested Capital | -16.87% |
| Profit Margin (Quarterly) | -22.13% |
| Operating Margin (Quarterly) | -13.01% |
| Return on Net Operating Assets | -27.78% |